Xconomy

OCTOBER 7, 2016

. —Alnylam Pharmaceuticals (NASDAQ: ALNY ) of Cambridge, MA, said that it would shelve its drug revusiran after 18 patients died in a Phase 3 study to treat the rare disease transthyretin amyloidosis. PRICE FIGHTS. With some caveats, ICER recommended lower prices. Shares immediately fell more than 40 percent.

Technical Review 77

Technical Review Study Layoffs San Diego 77

Both Sides of the Table

JANUARY 25, 2014

He just had his Mitt Romney moment and his name will forever be etched in the collective consciousness of the tech community for this terribly insensitive and tone deaf letter to the Wall Street Journal. We have outrage over the rising real-estate prices which these “techno geeks” can pay. ”".

Education 417

Education Venture Capital UCSD Class 417

Both Sides of the Table

AUGUST 30, 2010

This post was originally published in a shorter (more sensible) format in the Wall Street Journal online. The prices of angel deals have recently crept up, VCs have also gotten their checkbooks out again, frothy deals are happening and people are feeling bullish. We took $2.3

Entrepreneur 298

Entrepreneur Venture Capital Technical Review Startup 298